tradingkey.logo


Alcon AG

ALC
79.190USD
+0.390+0.49%
āļ›āļīāļ” 12/15, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
39.17BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
37.40P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Alcon AG āļšāļĢāļīāļĐāļąāļ—

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

āļ‚āđ‰āļ­āļĄāļđāļĨ Alcon AG


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ALC
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Alcon AG
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 09, 2019
āļ‹āļĩāļ­āļĩāđ‚āļ­Endicott (David J)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™25599
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Apr 09
āļ—āļĩāđˆāļ­āļĒāļđāđˆRue Louis d'Affry 6
āđ€āļĄāļ·āļ­āļ‡FRIBOURG
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻSwitzerland
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ1700
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ41589113800
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.alcon.ch/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ALC
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 09, 2019
āļ‹āļĩāļ­āļĩāđ‚āļ­Endicott (David J)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Alcon AG


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
International
1.42B
54.99%
United States
1.16B
45.01%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 27 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 27 āļž.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
āļ­āļ·āđˆāļ™ āđ†
84.16%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
āļ­āļ·āđˆāļ™ āđ†
84.16%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
31.53%
Investment Advisor/Hedge Fund
24.78%
Bank and Trust
4.10%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.09%
Research Firm
1.93%
Pension Fund
1.41%
Individual Investor
0.13%
Insurance Company
0.07%
āļ­āļ·āđˆāļ™ āđ†
31.62%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
ZÞrcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Select Equity Group, L.P.
6.76M
1.35%
+1.28M
+23.44%
Jun 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Global X Aging Population ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.36%
Franklin FTSE Switzerland ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.28%
iShares MSCI Switzerland ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.2%
First Trust Indxx Medical Devices ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.06%
Running Oak Efficient Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.77%
Global X S&P Catholic Values Developed ex-US ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.07%
JPMorgan BetaBuilders Europe ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.59%
iShares Global Healthcare ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.53%
ALPS O'Shares International Developed Quality Dividend ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.45%
Wahed Dow Jones Islamic World ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.44%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 400.00M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āđƒāļ„āļĢāļ„āļ·āļ­āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Alcon AG?


āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Alcon AG āđ„āļ”āđ‰āđāļāđˆ:
BlackRock Advisors (UK) Limited āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 24.68M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.94% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
The Vanguard Group, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 20.64M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.13% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
UBS Fund Management (Switzerland) AG āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 11.47M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 2.29% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Norges Bank Investment Management (NBIM) āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 11.35M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 2.27% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Aristotle Capital Management, LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 12.04M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 2.41% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”

āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Alcon AG āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Alcon AG āđ„āļ”āđ‰āđāļāđˆ
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG

āļĄāļĩāļāļĩāđˆāļŠāļ–āļēāļšāļąāļ™āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Alcon AG (ALC)?


āļ“ āļ§āļąāļ™āļ—āļĩāđˆ 2025Q4 āļĄāļĩāļŠāļ–āļēāļšāļąāļ™āļˆāļģāļ™āļ§āļ™ 1623 āđāļŦāđˆāļ‡āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Alcon AG āđ‚āļ”āļĒāļĄāļĩāļĄāļđāļĨāļ„āđˆāļēāļĢāļ§āļĄāļ›āļĢāļ°āļĄāļēāļ“ 342.44M āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 72.26% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” āđ€āļĄāļ·āđˆāļ­āđ€āļ—āļĩāļĒāļšāļāļąāļšāļ§āļąāļ™āļ—āļĩāđˆ 2025Q3 āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™āđ„āļ”āđ‰āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™ -0.16%

āđāļŦāļĨāđˆāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŦāļĨāļąāļāļ‚āļ­āļ‡ Alcon AG āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āđ€āļĄāļ·āđˆāļ­āļ§āļąāļ™āļ—āļĩāđˆ FY2025Q2 āļ˜āļļāļĢāļāļīāļˆāļ”āđ‰āļēāļ™ Consumables āļŠāļĢāđ‰āļēāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāđ‰āļāļąāļš Alcon AG āļ„āļīāļ”āđ€āļ›āđ‡āļ™āļĄāļđāļĨāļ„āđˆāļē 777.00M āđāļĨāļ°āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 30.15% āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļĢāļ§āļĄ
KeyAI
î™